AplusA

COVID-19 INFO #1: Data Collection

COVID-19

AplusA teams have been receiving questions regarding the impact of COVID-19 on market research...

COVID-19 Message of Thanks to AplusA Healthcare Professional Study Participants

Doctor Christine Maï, AplusA Executive Vice-President, sent the following message to the...

AplusA COVID-19 Business Continuity Plan

In light of the current global COVID-19 outbreak, we wanted to share key points from AplusA's...

DLBCL Case Study: Enhancing Patient Journey Research with Social Media Listening

Products and Services, Healthcare Industry, Market Research Industry, Digital

Using the example of a recent AplusA study in Diffuse Large B-Cell Lymphoma (DLBCL), we consider...

Patient Insights from AplusA’s Multiple Myeloma Tracker

hemato-oncology

A thoughtfully developed tracker can provide deep insights on any therapeutic area. Using the...

Multiple Myeloma Market Dynamics Revealed by AplusA Tracker

hemato-oncology

A thoughtfully developed tracker can provide deep insights on any therapeutic area. Using the...

Brand Performance Insights from AplusA's Multiple Myeloma Tracker

hemato-oncology

A thoughtfully developed tracker can provide deep insights on any therapeutic area. Using the...

Key Insights from a Multiple Myeloma Tracker

hemato-oncology

A thoughtfully developed tracker can provide deep insights on any therapeutic area. Using the...

EphMRA 2019: Future Leaders Winning Case Study

Availability vs Patient Usage of New Digital GP Services

Healthcare Industry, Digital

New apps and devices are constantly being designed with the intention of simplifying or...